AQ
Aarfa Queen
University of Nebraska Medical Center, Jamia Millia Islamia, Jamia Millia Islamia Faculty of Natural Sciences, Kurukshetra University
0000-0001-9750-5301
Employment
-
University of Nebraska Medical Center Postdoctoral Research Associate2022 - Present
-
Jamia Millia Islamia ICMR Senior Research Fellow2019 - 2021
Education
-
Jamia Millia Islamia M. Phil.2013 - 2016
-
Jamia Millia Islamia Faculty of Natural Sciences M. Sc.2011 - 2013
-
Kurukshetra University B. Sc.2008 - 2011
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Imidazole Bioisostere Activators of Endopeptidase Neurolysin with Enhanced Potency and Metabolic Stability. Save
- Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma. Save
- Discovery of the Next Generation of Non-peptidomimetic Neurolysin Activators with High Blood-Brain Barrier Permeability: a Pharmacokinetics Study in Healthy and Stroke Animals. Save
- Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation. Save
- Targeting cyclin-dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies. Save
- Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy. Save
- Structural Features of Nucleoprotein CST/Shelterin Complex Involved in the Telomere Maintenance and Its Association with Disease Mutations. Save
- Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX. Save
- Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy. Save
- Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases. Save